News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
AstraZeneca PLC Settles Seroquel Case; Agrees to Pay $520 Million to Settle Investigation
April 27, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Drug maker AstraZeneca has agreed to pay $520 million to settle a federal investigation into its marketing practices for the antipsychotic drug Seroquel, the New York Times reported on its website on Monday.
Twitter
LinkedIn
Facebook
Email
Print
Legal
AstraZeneca
MORE ON THIS TOPIC
Legal
Nektar prevails in legal battle with Lilly over broken rezpeg partnership
September 25, 2026
·
2 min read
·
Annalee Armstrong
China
China’s surging biotech sector represents both competition and lifeline for the US
September 23, 2026
·
8 min read
·
Shawna Williams
China
FDA raises bar for foreign site inspections as China trials surge
September 2, 2026
·
4 min read
·
Heather McKenzie
Regulatory
Tavneos no longer available for new patients in UK as Amgen awaits FDA hearing
September 2, 2026
·
2 min read
·
Tristan Manalac